Rivaroxaban Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 10 mg, 15 mg, 20 mg

Reference Brands: Xarelto(US & EU)

Category: Blood Disorder

Rivaroxaban inhibits factor Xa, reducing thrombin generation and clot formation. It effectively prevents strokes, deep vein thrombosis, and pulmonary embolism. Benefits include oral administration, predictable effects, no routine blood monitoring needed, and rapid onset, making it a convenient and effective anticoagulant for both prophylaxis and treatment of thromboembolic disorders. Rivaroxaban tablets is available in Tablet and strengths such as 10 mg, 15 mg, 20 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Rivaroxaban tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Rivaroxaban tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Rivaroxaban is a widely used oral anticoagulant regulated by the FDA in the US and the EMA in the EU. It requires a robust dossier demonstrating safety, efficacy, and manufacturing quality for approval. In the US, it is approved as Xarelto, with a focus on stroke prevention, DVT, and PE treatment. In the EU, similar approvals are granted through centralized procedures, ensuring compliance with regional standards. For expert guidance on dossier preparation, regulatory pathways, and market entry strategies, visit PharmaTradz. Ensuring regulatory compliance is critical for successful registration and commercialization of rivaroxaban products globally.